GM-CSF treatment is not effective in congenital neutropenia patients due to its inability to activate NAMPT signaling (Q40410872)

From Wikidata
Jump to navigation Jump to search
scientific article published on 14 December 2016
edit
Language Label Description Also known as
English
GM-CSF treatment is not effective in congenital neutropenia patients due to its inability to activate NAMPT signaling
scientific article published on 14 December 2016

    Statements

    GM-CSF treatment is not effective in congenital neutropenia patients due to its inability to activate NAMPT signaling (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit